首页 | 本学科首页   官方微博 | 高级检索  
     


Biopsy Based Proteomic Assay Predicts Risk of Biochemical Recurrence after Radical Prostatectomy
Authors:Fred Saad  Mathieu Latour  Jean-Baptiste Lattouf  Hugues Widmer  Kevin C. Zorn  Anne-Marie Mes-Masson  Veronique Ouellet  Genevieve Saad  Amol Prakash  Sibgat Choudhury  Gang Han  Pierre Karakiewicz  Jerome P. Richie
Affiliation:1. Centre Hospitalier de l''Université de Montréal, Montreal, Quebec, Canada;2. Université de Montréal Endowed Chair in Prostate Cancer, Montreal, Quebec, Canada;3. Centre de recherche du Centre Hospitalier de l''Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada;4. Department of Surgery, Université de Montréal, Montreal, Quebec, Canada;5. Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Quebec, Canada;6. Department of Medicine, Université de Montréal, Montreal, Quebec, Canada;7. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada;8. Metamark Genetics, Inc., Cambridge, Massachusetts;9. Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas
Abstract:
Keywords:prostatic neoplasms  biomarkers  cancer  biopsy  neoplasm recurrence  local  watchful waiting  BCR  biochemical relapse  CHUM  Centre hospitalier de l’Université de Montréal  NCCN®  National Comprehensive Cancer Network®  PSA  prostate specific antigen  RP  radical prostatectomy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号